Nippon India Pharma Fund Add to compare
211.2152
6.4394
(3.14%)
1 day change as on 31 Jul 2020
Investment Objective: To generate consistent returns by investing in equity or fixed income securities of pharma and other associated companies.
Fund Type Entry Load Average Asset Size (Rs cr.)
Open Ended Nil 2878.39
Investment Plan Exit Load Minimum Investment (Rs.)
Growth If redeemed bet. 0 Day to 30 Days; Exit Load is 1% 5000
Launch Date Fund Manager Last Dividend
05-06-2004 Sailesh Raj Bhan 0.00
Benchmark Email / Website Bonus
S&P BSE HC TRI customer_care@reliancemutual.com / www.reliancemutual.com
AMC Name
Nippon India Mutual Fund
Fund Name AUM (Rs. Cr) Return (%)
1 Mth 3 Mths 6 Mths 1 Yr 3 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund 3092.66 11.66 17.55 35.26 54.15 17.71 8.41 20.77
Mirae Asset Healthcare Fund 640.00 13.41 18.74 38.56 60.99 -- -- 24.81
DSP Healthcare Fund 474.81 12.41 21.33 30.88 58.12 -- -- 29.46
ICICI Prudential Pharma Healthcare and Diagnostics Fund 1522.96 12.61 22.02 37.12 54.37 -- -- 20.81
UTI Healthcare Fund 480.89 13.42 18.63 34.83 52.15 11.48 4.18 13.87
SBI Healthcare Opportunities Fund 1154.42 12.08 16.60 30.84 51.70 8.58 2.68 15.55
Top 10 Holdings
Company Name Sector Name Asset %
Aurobindo Pharma Ltd. Pharma 10.48
Cipla Ltd. Pharma 9.94
Sun Pharmaceuticals Industries Ltd. Pharma 9.64
Dr Reddys Laboratories Ltd. Pharma 9.5
Lupin Ltd. Pharma 9.43
 
Company Name Sector Name Asset %
Divis Laboratories Ltd. Pharma 7.74
Syngene International Ltd Pharma 6.35
Fortis Healthcare Ltd. Healthcare Services 5.68
Sanofi India Ltd Pharma 4.46
Thyrocare Technologies Ltd. Healthcare Services 4.2
AUM Movement
Asset Allocation